Human Beta-defensin-1 (hBD-1)

Send Inquiry
Human Beta-defensin-1 (hBD-1)
Details
•Product Name: Human β-defensin-1 (hBD-1)
•CAS No.: 452274-53-2
•Sequence: DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK
•Length: 36 amino acids
•Disulfide bonds: Cys5-Cys20; Cys12-Cys31; Cys17-Cys35 (canonical beta-defensin pairing)
•Molecular Formula: C167H256N48O50S6
•Molecular Weight: 3928.53 Da
•Origin: Epithelial secretion (respiratory, urogenital tract, skin, oral cavity)
•Purity: HPLC ≥95%
Related Docs: COA/MS/HPLC Report, Peptide Solubility and Storage Guide
Category
Antimicrobial Peptides
Share to
Description

Shanghai Sonyt Biotechnology Co., Ltd. is one of the leading manufacturers and suppliers of human beta-defensin-1 (hbd-1) in China, also supports custom service. Welcome to wholesale bulk high quality human beta-defensin-1 (hbd-1) from our factory. Contact us for more details.

 

Description Human β-defensin-1 (CAS: 452274-53-2, hBD-1/DEFB1) is the prototypical 36-residue cationic beta-defensin, sequence DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK, with six cysteines forming three canonical disulfide bonds (Cys5-Cys20, Cys12-Cys31, Cys17-Cys35). Molecular formula C167H256N48O50S6, MW 3928.53 Da. Constitutively secreted by respiratory, urogenital, oral, and skin epithelia, hBD-1 kills Gram-positive/Gram-negative bacteria, yeasts, and anaerobes by membrane disruption, serving as a key effector of mucosal and cutaneous barrier innate immunity; altered hBD-1 expression is linked to inflammatory bowel disease, psoriasis, and autoimmunity. hBD-1 is a tool for epithelial barrier defense, beta-defensin structure, and innate-adaptive immune bridging.
Structure type 36-residue cationic peptide (6 Cys / 3 disulfide bonds; human epithelial beta-defensin prototype)
Solubility Readily soluble in water, dilute acetic acid
Storage Powder -20C, dry, protected from light

 

Product Basic Information Table

 

Product Standard English Name Product Abbreviation / Alias Function Tags (comma-separated) Core Structure Molecular Formula Exact Mass (Da) Average MW (Da) Salt Form Length (aa)
Human beta-defensin-1 (hBD-1) hBD-1; HBD1; DEFB1; DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK; 36-aa mature peptide; 3 disulfide bonds; CAS 452274-53-2; PDB 1IJV/1HJ0 human beta-defensin, epithelial antimicrobial peptide, cationic cysteine-rich peptide, 3 disulfide bonds, triple-stranded antiparallel beta-sheet, CCR6 chemokine, epithelial innate immunity, reducing-agent sensitive, folding-sensitive 36-aa human cationic cysteine-rich AMP, Asp1-His2-Tyr3-Asn4-Cys5-Val6-Ser7-Ser8-Gly9-Gly10-Gln11-Cys12-Leu13-Tyr14-Ser15-Ala16-Cys17-Pro18-Ile19-Phe20-Thr21-Lys22-Ile23-Gln24-Gly25-Thr26-Cys27-Tyr28-Arg29-Gly30-Lys31-Ala32-Lys33-Cys34-Cys35-Lys36 (DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK); encoded by human DEFB1, constitutively expressed by renal tubule, respiratory, oral, skin and other epithelia exposed to microbes; 6 Cys (positions 5, 12, 17, 27, 34, 35) form 3 intramolecular disulfide bonds in the canonical beta-defensin pattern Cys5-Cys34 (CysI-CysV), Cys12-Cys27 (CysII-CysIV), Cys17-Cys35 (CysIII-CysVI), stabilizing a short N-terminal alpha-helix plus three-stranded antiparallel beta-sheet; free N-terminus +1, free C-terminus -1, side-chain charge = 4 Lys (22,31,33,36) + 1 Arg (29) + 1 His (2) - 1 Asp (1) = +5 theoretical (often reported as +4 at physiological pH where His2 is largely unprotonated); contains 3 Tyr (3,14,28), 1 Pro (18), 1 Phe (20); no Met or Trp; 22% hydrophobic residues, overall hydrophilic and charged C167H256N48O50S6 3925.73 3928.53 Free base / oxidized form; supplied as the oxidized folded form (3 disulfides); formula and MW calculated for the oxidized peptide, matching the originally reported 3928.6 Da 36

 

Physicochemical Solubility & Storage Parameters

 

Product Code Appearance Long-term Storage Short-term Storage Solution Stability Solid Powder Stability
PEP-HBD1-01 White powder -20°C, desiccated, sealed, light-protected; the 3 disulfides maintain the beta-sheet fold, so avoid reducing agents (DTT/TCEP/beta-ME), high temperature and extreme pH; aliquot under argon and avoid repeated freeze-thaw; note that reduction of hBD-1 paradoxically enhances its direct antibacterial activity but abolishes its chemotactic activity 2-8°C, desiccated and light-protected, stable for 1-2 weeks Cationic hydrophilic folded peptide (net +5), good water solubility, dissolves in water or dilute acetic acid (0.01-0.1%); first dissolve in water or dilute acetic acid then dilute into neutral buffer; do not co-incubate with reducing agents, which unfold the beta-sheet and alter chemotactic activity; aliquot solutions at -20°C, avoid freeze-thaw; avoid prolonged exposure above 37°C to prevent beta-sheet unfolding Disulfides and beta-sheet fold are stable in the solid; for long-term keep dry at -20°C, sealed; hygroscopic, seal tightly

 

Functional Description

 

Product Code Frontend Short Summary Detailed Biological Function Description Applicable Research Areas (comma-separated) Targets / Pathways
PEP-HBD1-01 A 36-residue cationic epithelial AMP encoded by human DEFB1 (DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK); 6 Cys form 3 conserved disulfides (5-34/12-27/17-35); net +5; combines direct antimicrobial activity with CCR6-mediated chemotaxis of immature dendritic cells and memory T cells; a core effector of human epithelial innate immunity. Human beta-defensin-1 (hBD-1) is the first human beta-defensin, isolated from human blood filtrate by Harder and colleagues in 1995 and confirmed by cDNA cloning; it is encoded by DEFB1 and constitutively produced by renal tubular, respiratory epithelial, oral mucosal, skin, salivary-gland, pancreatic and prostatic epithelial surfaces directly exposed to the microbial environment. The mature peptide is 36 residues long: DHYNCVSSGGQCLYSACPIFTKIQGTCYRGKAKCCK. Its six cysteines (Cys5, 12, 17, 27, 34, 35) form three intramolecular disulfide bonds in the canonical beta-defensin pattern-Cys5-Cys34, Cys12-Cys27 and Cys17-Cys35-stabilizing a compact globular fold comprising a short N-terminal alpha-helix and a three-stranded antiparallel beta-sheet (PDB 1IJV/1HJ0). As a cationic AMP, hBD-1 electrostatically engages anionic bacterial phospholipids, LPS/lipoteichoic acids and permeabilizes membranes, exerting moderate bactericidal/fungistatic activity against E. coli, S. aureus, P. aeruginosa, C. albicans and related microbes. Notably, its direct antibacterial activity is milder than hBD-2/hBD-3, and reduction of the disulfides paradoxically increases antibacterial activity, indicating that in hBD-1 the disulfides act not merely as structural staples but as activity switches. Beyond direct killing, hBD-1 functions importantly as an alarmin/chemokine-like mediator: it signals through CCR6 to recruit immature dendritic cells and memory T cells to sites of infection, and can trigger mast-cell degranulation and cytokine release, thereby bridging innate and adaptive immunity. hBD-1 is also implicated in wound healing, reproductive defense (present in semen), skin barrier homeostasis and multiple diseases-DEFB1 polymorphisms are associated with asthma, psoriasis, chronic pancreatitis, HIV susceptibility and oncogenesis. Supplied as the oxidized folded mature free peptide, this product is a useful tool for epithelial innate immunity, defensin folding/disulfide regulation, CCR6 chemotactic signaling, mucosal anti-infection and skin-barrier studies; keep reducing agents away to preserve the native chemotactic conformation, or use controlled reduction if the enhanced reduced-state antibacterial activity is the object of study. human epithelial innate immunity, beta-defensin family, cationic cysteine-rich AMPs, disulfide folding regulation, CCR6 chemotactic signaling, mucosal anti-infection, skin barrier, alarmin/immunomodulatory peptide, DEFB1 disease associations bacterial/fungal membranes (permeabilization), CCR6 chemokine receptor (immature dendritic cell / memory T-cell chemotaxis), mast cells; disulfides Cys5-Cys34/Cys12-Cys27/Cys17-Cys35 are essential for folding

 

 

 

 

Hot Tags: human beta-defensin-1 (hbd-1), China human beta-defensin-1 (hbd-1) manufacturers, suppliers, factory, 3032621-32-9, CAS 79404 91 4, CAS 849352 44 9, Cilofungin, CP7-FP13-2, Elf18

Send Inquiry